{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:32:09Z","timestamp":1785544329648,"version":"3.56.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000620-02"],"award-info":[{"award-number":["Z1A DA000620-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000633-01"],"award-info":[{"award-number":["Z1A DA000633-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41386-020-00885-4","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T05:02:43Z","timestamp":1602910963000},"page":"860-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Beta-caryophyllene inhibits cocaine\u00a0 addiction-related behavior by activation of PPAR\u03b1 and PPAR\u03b3: repurposing a FDA-approved food additive for cocaine use disorder"],"prefix":"10.1038","volume":"46","author":[{"given":"Ewa","family":"Galaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allamar","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"key":"885_CR1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760\u201373.","journal-title":"Lancet Psychiatry."},{"key":"885_CR2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40263-019-00664-w","volume":"33","author":"E Galaj","year":"2019","unstructured":"Galaj E, Xi Z-X. Potential of cannabinoid receptor ligands as treatment for substance use disorders. CNS Drugs. 2019;33:1001\u201330.","journal-title":"CNS Drugs."},{"key":"885_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","volume":"157","author":"J Manzanares","year":"2018","unstructured":"Manzanares J, Caba\u00f1ero D, Puente N, Garc\u00eda-Guti\u00e9rrez MS, Grandes P, Maldonado R. Role of the endocannabinoid system in drug addiction. Biochem Pharmacol. 2018;157:108\u201321.","journal-title":"Biochem Pharmacol"},{"key":"885_CR4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2005.02.015","volume":"81","author":"JC Arnold","year":"2005","unstructured":"Arnold JC. The role of endocannabinoid transmission in cocaine addiction. Pharm Biochem Behav. 2005;81:396\u2013406.","journal-title":"Pharm Biochem Behav."},{"key":"885_CR5","doi-asserted-by":"crossref","first-page":"107740","DOI":"10.1016\/j.neuropharm.2019.107740","volume":"167","author":"E Galaj","year":"2020","unstructured":"Galaj E, Bi G-H, Yang H-J, Xi Z-X. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms. Neuropharmacology. 2020;167:107740.","journal-title":"Neuropharmacology."},{"key":"885_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1369-1600.2008.00109.x","volume":"13","author":"J Wiskerke","year":"2008","unstructured":"Wiskerke J, Pattij T, Schoffelmeer ANM, De, Vries TJ. The role of CB1 receptors in psychostimulant addiction. Addict Biol. 2008;13:225\u201338.","journal-title":"Addict Biol."},{"key":"885_CR7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","volume":"33","author":"Z-X Xi","year":"2008","unstructured":"Xi Z-X, Spiller K, Pak AC, Gilbert J, Dillon C, Li X, et al. Cannabinoid cb1 receptor antagonists attenuate cocaine\u2019s rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology. 2008;33:1735\u201345.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","volume":"14","author":"Z-X Xi","year":"2011","unstructured":"Xi Z-X, Peng X-Q, Li X, Song R, Zhang H-Y, Liu Q-R, et al. Brain cannabinoid CB2 receptors modulate cocaine\u2019s actions in mice. Nat Neurosci. 2011;14:1160\u20136.","journal-title":"Nat Neurosci."},{"key":"885_CR9","first-page":"269","volume":"20","author":"F Delis","year":"2017","unstructured":"Delis F, Polissidis A, Poulia N, Justinova Z, Nomikos GG, Goldberg SR, et al. Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid cb2 receptor agonism and cb1 receptor antagonism in rats. Int J Neuropsychopharmacol. 2017;20:269\u201378.","journal-title":"Int J Neuropsychopharmacol."},{"key":"885_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-019-05370-5","volume":"237","author":"JB Lopes","year":"2020","unstructured":"Lopes JB, Bastos JR, Costa RB, Aguiar DC, Moreira FA. The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice. Psychopharmacol. (Berl) 2020;237:385\u201394.","journal-title":"Psychopharmacol. (Berl)"},{"key":"885_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2010.10.008","volume":"217","author":"L-L Yu","year":"2011","unstructured":"Yu L-L, Zhou S-J, Wang X-Y, Liu J-F, Xue Y-X, Jiang W, et al. Effects of cannabinoid CB1 receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice. Behav Brain. Res 2011;217:111\u20136.","journal-title":"Behav Brain. Res"},{"key":"885_CR12","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"H-Y Zhang","year":"2014","unstructured":"Zhang H-Y, Gao M, Liu Q-R, Bi G-H, Li X, Yang H-J, et al. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci USA. 2014;111:E5007\u20135015.","journal-title":"Proc Natl Acad Sci USA."},{"key":"885_CR13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","volume":"7","author":"TJ De Vries","year":"2001","unstructured":"De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, et al. A cannabinoid mechanism in relapse to cocaine seeking. Nat Med. 2001;7:1151\u20134.","journal-title":"Nat Med."},{"key":"885_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2009.07.002","volume":"105","author":"SJ Ward","year":"2009","unstructured":"Ward SJ, Rosenberg M, Dykstra LA, Walker EA. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse. Drug Alcohol Depend. 2009;105:248\u201355.","journal-title":"Drug Alcohol Depend"},{"key":"885_CR15","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","volume":"26","author":"Z-X Xi","year":"2006","unstructured":"Xi Z-X, Gilbert JG, Peng X-Q, Pak AC, Li X, Gardner EL. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci. 2006;26:8531\u20136.","journal-title":"J Neurosci"},{"key":"885_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euroneuro.2004.04.003","volume":"15","author":"HMB Lesscher","year":"2005","unstructured":"Lesscher HMB, Hoogveld E, Burbach JPH, van Ree JM, Gerrits MAFM. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur Neuropsychopharmacol. 2005;15:31\u201337.","journal-title":"Eur Neuropsychopharmacol"},{"key":"885_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","volume":"118","author":"G Cossu","year":"2001","unstructured":"Cossu G, Ledent C, Fattore L, Imperato A, B\u00f6hme GA, Parmentier M, et al. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res. 2001;118:61\u201365.","journal-title":"Behav Brain Res."},{"key":"885_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(99)00059-5","volume":"104","author":"L Fattore","year":"1999","unstructured":"Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res. 1999;104:141\u20136.","journal-title":"Behav Brain Res."},{"key":"885_CR19","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1523\/JNEUROSCI.4403-06.2007","volume":"27","author":"S Caill\u00e9","year":"2007","unstructured":"Caill\u00e9 S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci. 2007;27:3695\u2013702.","journal-title":"J Neurosci."},{"key":"885_CR20","first-page":"806","volume":"58","author":"M Filip","year":"2006","unstructured":"Filip M, Go\u0142da A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W, et al. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharm Rep. 2006;58:806\u201319.","journal-title":"Pharm Rep."},{"key":"885_CR21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","volume":"3","author":"G Tanda","year":"2000","unstructured":"Tanda G, Munzar P, Goldberg SR. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci. 2000;3:1073\u20134.","journal-title":"Nat Neurosci."},{"key":"885_CR22","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1046\/j.1460-9568.2000.00287.x","volume":"12","author":"M Martin","year":"2000","unstructured":"Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci. 2000;12:4038\u201346.","journal-title":"Eur J Neurosci."},{"key":"885_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FBP.0b013e32830ded11","volume":"19","author":"LL Miller","year":"2008","unstructured":"Miller LL, Ward SJ, Dykstra LA. Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice. Behav Pharmacol. 2008;19:575\u201381.","journal-title":"Behav Pharmacol."},{"key":"885_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1432-0","volume":"204","author":"X Li","year":"2009","unstructured":"Li X, Hoffman AF, Peng X-Q, Lupica CR, Gardner EL, Xi Z-X. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice. Psychopharmacol (Berl). 2009;204:1\u201311.","journal-title":"Psychopharmacol (Berl)"},{"key":"885_CR25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/npp.2012.22","volume":"37","author":"A Aracil-Fern\u00e1ndez","year":"2012","unstructured":"Aracil-Fern\u00e1ndez A, Trigo JM, Garc\u00eda-Guti\u00e9rrez MS, Ortega-\u00c1lvaro A, Ternianov A, Navarro D, et al. Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB2 receptors. Neuropsychopharmacology. 2012;37:1749\u201363.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","volume":"205","author":"B Le Foll","year":"2009","unstructured":"Le Foll B, Gorelick DA, Goldberg SR. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology. 2009;205:171\u20134.","journal-title":"Psychopharmacology."},{"key":"885_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","volume":"98","author":"CJ Jordan","year":"2019","unstructured":"Jordan CJ, Xi Z-X. Progress in brain cannabinoid CB2 receptor research: From genes to behavior. Neurosci Biobehav Rev. 2019;98:208\u201320.","journal-title":"Neurosci Biobehav Rev."},{"key":"885_CR28","first-page":"80","volume":"4","author":"V Mediavilla","year":"1997","unstructured":"Mediavilla V, Steinemann S. Essential oil of cannabis sativa L. strains. I Int Hemp Res. 1997;4:80\u20132.","journal-title":"I Int Hemp Res"},{"key":"885_CR29","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2174\/1381612822666160311115226","volume":"22","author":"C Sharma","year":"2016","unstructured":"Sharma C, Al Kaabi JM, Nurulain SM, Goyal SN, Kamal MA, Ojha S. Polypharmacological properties and therapeutic potential of \u03b2-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise. Curr Pharm Des. 2016;22:3237\u201364.","journal-title":"Curr Pharm Des."},{"key":"885_CR30","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen J-Z, Xie X-Q, et al. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA. 2008;105:9099\u2013104.","journal-title":"Proc Natl Acad Sci USA."},{"key":"885_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.lfs.2006.11.038","volume":"80","author":"JY Cho","year":"2007","unstructured":"Cho JY, Chang H-J, Lee S-K, Kim H-J, Hwang J-K, Chun HS. Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sci. 2007;80:932\u20139.","journal-title":"Life Sci."},{"key":"885_CR32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","volume":"24","author":"A-L Klauke","year":"2014","unstructured":"Klauke A-L, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol. 2014;24:608\u201320.","journal-title":"Eur Neuropsychopharmacol"},{"key":"885_CR33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","volume":"17","author":"S Katsuyama","year":"2013","unstructured":"Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, et al. Involvement of peripheral cannabinoid and opioid receptors in \u03b2-caryophyllene-induced antinociception. Eur J Pain. 2013;17:664\u201375.","journal-title":"Eur J Pain."},{"key":"885_CR34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","volume":"135","author":"A Bahi","year":"2014","unstructured":"Bahi A, Al Mansouri S, Al Memari E, Al Ameri M, Nurulain SM, Ojha S. \u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav. 2014;135:119\u201324.","journal-title":"Physiol Behav."},{"key":"885_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362689","volume":"94","author":"Y Cheng","year":"2014","unstructured":"Cheng Y, Dong Z, Liu S. \u03b2-caryophyllene ameliorates the alzheimer-like phenotype in APP\/PS1 mice through CB2 receptor activation and the PPAR\u03b3 pathway. Pharmacology. 2014;94:1\u201312.","journal-title":"Pharmacology."},{"key":"885_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12031-014-0243-5","volume":"54","author":"K Guo","year":"2014","unstructured":"Guo K, Mou X, Huang J, Xiong N, Li H. Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-\u03baB activation in microglia. J Mol Neurosci. 2014;54:41\u20138.","journal-title":"J Mol Neurosci."},{"key":"885_CR37","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/cam4.816","volume":"5","author":"K Fidyt","year":"2016","unstructured":"Fidyt K, Fiedorowicz A, Strz\u0105da\u0142a L, Szumny A. \u03b2-caryophyllene and \u03b2-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer Med. 2016;5:3007\u201317.","journal-title":"Cancer Med."},{"key":"885_CR38","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/bph.14969","volume":"177","author":"Y He","year":"2020","unstructured":"He Y, Galaj E, Bi G-H, Wang X-F, Gardner E, Xi Z-X. \u03b2-caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents. Br J Pharmacol. 2020;177:2058\u201372.","journal-title":"Br J Pharmacol."},{"key":"885_CR39","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","volume":"178","author":"AF Bento","year":"2011","unstructured":"Bento AF, Marcon R, Dutra RC, Claudino RF, Cola M, Pereira Leite DF, et al. \u03b2-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPAR\u03b3 pathway. Am J Pathol. 2011;178:1153\u201366.","journal-title":"Am J Pathol."},{"key":"885_CR40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bph.13722","volume":"175","author":"ZV Varga","year":"2018","unstructured":"Varga ZV, Matyas C, Erdelyi K, Cinar R, Nieri D, Chicca A, et al. \u03b2\u2010Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. Br J Pharmacol. 2018;175:320\u201334.","journal-title":"Br J Pharmacol."},{"key":"885_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphar.2020.00359","volume":"11","author":"DB Finlay","year":"2020","unstructured":"Finlay DB, Sircombe KJ, Nimick M, Jones C, Glass M. Terpenoids From cannabis do not mediate an entourage effect by acting at cannabinoid receptors. Front Pharmacol. 2020;11:359. https:\/\/doi.org\/10.3389\/fphar.2020.00359.","journal-title":"Front Pharmacol"},{"key":"885_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/can.2019.0016","volume":"4","author":"M Santiago","year":"2019","unstructured":"Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M. Absence of entourage: terpenoids commonly found in cannabis sativa do not modulate the functional activity of \u03949-THC at human CB1 and CB2 receptors. Cannabis Cannabinoid Res. 2019;4:165\u201376.","journal-title":"Cannabis Cannabinoid Res."},{"key":"885_CR43","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","volume":"177","author":"X-F Wang","year":"2020","unstructured":"Wang X-F, Galaj E, Bi G-H, Zhang C, He Y, Zhan J, et al. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB1 \/CB2 versus GPR55 receptors. Br J Pharmacol. 2020;177:1865\u201380.","journal-title":"Br J Pharmacol."},{"key":"885_CR44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/npp.2014.268","volume":"40","author":"G de Guglielmo","year":"2015","unstructured":"de Guglielmo G, Melis M, De Luca MA, Kallupi M, Li HW, Niswender K, et al. PPAR\u03b3 activation attenuates opioid consumption and modulates mesolimbic dopamine transmission. Neuropsychopharmacology. 2015;40:927\u201337.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuropharm.2016.07.024","volume":"110","author":"S Scheggi","year":"2016","unstructured":"Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, et al. PPAR\u03b1 modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 2016;110:251\u20139.","journal-title":"Neuropharmacology."},{"key":"885_CR46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.phymed.2013.08.006","volume":"21","author":"LIG Paula-Freire","year":"2014","unstructured":"Paula-Freire LIG, Andersen ML, Gama VS, Molska GR, Carlini ELA. The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine. 2014;21:356\u201362.","journal-title":"Phytomedicine."},{"key":"885_CR47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2015.12.019","volume":"245","author":"RH Basha","year":"2016","unstructured":"Basha RH, Sankaranarayanan C. \u03b2-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem Biol Interact. 2016;245:50\u20138.","journal-title":"Chem Biol Interact."},{"key":"885_CR48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2013.11.136","volume":"444","author":"W Suijun","year":"2014","unstructured":"Suijun W, Zhen Y, Ying G, Yanfang W. A role for trans-caryophyllene in the moderation of insulin secretion. Biochem Biophys Res Commun. 2014;444:451\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"885_CR49","doi-asserted-by":"crossref","first-page":"112439","DOI":"10.1016\/j.bbr.2019.112439","volume":"380","author":"E-S Hwang","year":"2020","unstructured":"Hwang E-S, Kim H-B, Lee S, Kim M-J, Kim K-J, Han G, et al. Antidepressant-like effects of \u03b2-caryophyllene on restraint plus stress-induced depression. Behav Brain Res. 2020;380:112439.","journal-title":"Behav Brain Res."},{"key":"885_CR50","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/ijms18040691","volume":"18","author":"TB Alberti","year":"2017","unstructured":"Alberti TB, Barbosa WLR, Vieira JLF, Raposo NRB, Dutra RC. (-)-\u03b2-caryophyllene, a cb2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis. Int J Mol Sci. 2017;18:691. https:\/\/doi.org\/10.3390\/ijms18040691.","journal-title":"Int J Mol Sci"},{"key":"885_CR51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopha.2017.04.092","volume":"91","author":"LBA Fontes","year":"2017","unstructured":"Fontes LBA, Dias DDS, Aarestrup BJV, Aarestrup FM, Da Silva Filho AA, Corr\u00eaa JO, et al. \u03b2-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL\/6 mice. Biomed Pharmacother. 2017;91:257\u201364.","journal-title":"Biomed Pharmacother."},{"key":"885_CR52","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.3390\/molecules200711808","volume":"20","author":"SS Dahham","year":"2015","unstructured":"Dahham SS, Tabana YM, Iqbal MA, Ahamed MBK, Ezzat MO, Majid ASA, et al. The anticancer, antioxidant and antimicrobial properties of the sesquiterpene \u03b2-caryophyllene from the essential oil of aquilaria crassna. Molecules. 2015;20:11808\u201329.","journal-title":"Molecules."},{"key":"885_CR53","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1211\/jpp.59.12.0005","volume":"59","author":"J Legault","year":"2007","unstructured":"Legault J, Pichette A. Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol. 2007;59:1643\u20137.","journal-title":"J Pharm Pharmacol"},{"key":"885_CR54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2018.11.043","volume":"360","author":"A Canseco-Alba","year":"2018","unstructured":"Canseco-Alba A, Schanz N, Sanabria B, Zhao J, Lin Z, Liu Q-R, et al. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons. Behav Brain Res. 2018;360:286\u201397.","journal-title":"Behav Brain Res."},{"key":"885_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.intimp.2017.07.009","volume":"51","author":"Y Hu","year":"2017","unstructured":"Hu Y, Zeng Z, Wang B, Guo S. Trans-caryophyllene inhibits amyloid \u03b2 (A\u03b2) oligomer-induced neuroinflammation in BV-2 microglial cells. Int Immunopharmacol. 2017;51:91\u20138.","journal-title":"Int Immunopharmacol"},{"key":"885_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnins.2016.00321","volume":"10","author":"H Javed","year":"2016","unstructured":"Javed H, Azimullah S, Haque ME, Ojha SK. Cannabinoid Type 2 (CB2) Receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of parkinson\u2019s disease. Front Neurosci. 2016;10:321.","journal-title":"Front Neurosci"},{"key":"885_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-016-2733-y","volume":"418","author":"S Ojha","year":"2016","unstructured":"Ojha S, Javed H, Azimullah S, Haque ME. \u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. Mol Cell Biochem. 2016;418:59\u201370.","journal-title":"Mol Cell Biochem."},{"key":"885_CR58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/ph10030060","volume":"10","author":"JM Viveros-Paredes","year":"2017","unstructured":"Viveros-Paredes JM, Gonz\u00e1lez-Casta\u00f1eda RE, Gertsch J, Chaparro-Huerta V, L\u00f3pez-Roa RI, V\u00e1zquez-Valls E, et al. Neuroprotective Effects of \u03b2-caryophyllene against dopaminergic neuron injury in a murine model of Parkinson\u2019s disease induced by MPTP. Pharmaceutical. 2017;10:60. https:\/\/doi.org\/10.3390\/ph10030060.","journal-title":"Pharmaceutical"},{"key":"885_CR59","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1111\/j.1750-3841.2008.00879.x","volume":"73","author":"YS Kim","year":"2008","unstructured":"Kim YS, Park SJ, Lee EJ, Cerbo RM, Lee SM, Ryu CH, et al. Antibacterial compounds from Rose Bengal-sensitized photooxidation of beta-caryophyllene. J Food Sci. 2008;73:C540\u20135.","journal-title":"J Food Sci"},{"key":"885_CR60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12917-016-0842-1","volume":"12","author":"JM Pieri","year":"2016","unstructured":"Pieri FA, Souza MC de C, Vermelho LLR, Vermelho MLR, Perciano PG, et al. Use of \u03b2-caryophyllene to combat bacterial dental plaque formation in dogs. BMC Vet Res. 2016;12:216. https:\/\/doi.org\/10.1186\/s12917-016-0842-1.","journal-title":"BMC Vet Res"},{"key":"885_CR61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ctcp.2018.10.004","volume":"33","author":"T Bahr","year":"2018","unstructured":"Bahr T, Allred K, Martinez D, Rodriguez D, Winterton P. Effects of a massage-like essential oil application procedure using copaiba and deep blue oils in individuals with hand arthritis. Complement Ther Clin Pract. 2018;33:170\u20136.","journal-title":"Complement Ther Clin Pract."},{"key":"885_CR62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4166\/kjg.2019.74.4.199","volume":"74","author":"HI Shim","year":"2019","unstructured":"Shim HI, Song DJ, Shin CM, Yoon H, Park YS, Kim N. et al. [Inhibitory effects of \u03b2-caryophyllene on helicobacter pylori infection: a randomized double-blind, placebo-controlled study]. Korean J Gastroenterol.2019;74:199\u2013204.","journal-title":"Korean J Gastroenterol."},{"key":"885_CR63","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1447-0756.2011.01802.x","volume":"38","author":"M-C Ou","year":"2012","unstructured":"Ou M-C, Hsu T-F, Lai AC, Lin Y-T, Lin C-C. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial. J Obstet Gynaecol Res. 2012;38:817\u201322.","journal-title":"J Obstet Gynaecol Res."},{"key":"885_CR64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","volume":"124","author":"S Al Mansouri","year":"2014","unstructured":"Al Mansouri S, Ojha S, Al Maamari E, Al Ameri M, Nurulain SM, Bahi A. The cannabinoid receptor 2 agonist, \u03b2-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharm Biochem Behav. 2014;124:260\u20138.","journal-title":"Pharm Biochem Behav."},{"key":"885_CR65","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.2174\/1381612824666180912151412","volume":"24","author":"PS Santos","year":"2018","unstructured":"Santos PS, Oliveira TC, R J\u00fanior LM, Figueiras A, Nunes LCC. \u03b2-caryophyllene delivery systems: enhancing the oral pharmacokinetic and stability. Curr Pharm Des. 2018;24:3440\u201353.","journal-title":"Curr Pharm Des."},{"key":"885_CR66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1091581816655303","volume":"35","author":"D Schmitt","year":"2016","unstructured":"Schmitt D, Levy R, Carroll B. Toxicological evaluation of \u03b2-caryophyllene oil: subchronic toxicity in rats. Int J Toxicol 2016;35:558\u201367.","journal-title":"Int J Toxicol"},{"key":"885_CR67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yrtph.2017.12.013","volume":"92","author":"GL Oliveira","year":"2018","unstructured":"Oliveira GL, da S, Machado KC, Machado KC, da Silva APDSCL, Feitosa CM, et al. Non-clinical toxicity of \u03b2-caryophyllene, a dietary cannabinoid: absence of adverse effects in female Swiss mice. Regul Toxicol Pharmacol 2018;92:338\u201346.","journal-title":"Regul Toxicol Pharmacol"},{"key":"885_CR68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/molecules25010106","volume":"25","author":"E Aly","year":"2019","unstructured":"Aly E, Khajah MA, Masocha W. \u03b2-Caryophyllene, a CB2-receptor-selective phytocannabinoid, suppresses mechanical allodynia in a mouse model of antiretroviral-induced neuropathic pain. Molecules. 2019;25:106. https:\/\/doi.org\/10.3390\/molecules25010106.","journal-title":"Molecules"},{"key":"885_CR69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1389557054368844","volume":"5","author":"JW Huffman","year":"2005","unstructured":"Huffman JW. CB2 receptor ligands. Mini Rev Med Chem. 2005;5:641\u20139.","journal-title":"Mini Rev Med Chem."},{"key":"885_CR70","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","volume":"40","author":"H-Y Zhang","year":"2015","unstructured":"Zhang H-Y, Bi G-H, Li X, Li J, Qu H, Zhang S-J, et al. Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats. Neuropsychopharmacology. 2015;40:1037\u201351.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR71","doi-asserted-by":"crossref","unstructured":"Gobira PH, Oliveira AC, Gomes JS, da Silveira VT, Asth L, Bastos JR, et al. Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine. Br J Pharmacol. 2018. 12, 10.1111\/bph.14473.","DOI":"10.1111\/bph.14473"},{"key":"885_CR72","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/adb.12367","volume":"22","author":"H-Y Zhang","year":"2017","unstructured":"Zhang H-Y, Gao M, Shen H, Bi G-H, Yang H-J, Liu Q-R, et al. Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats. Addict Biol. 2017;22:752\u201365.","journal-title":"Addict Biol"},{"key":"885_CR73","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","volume":"91","author":"DJ Foster","year":"2016","unstructured":"Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, et al. antipsychotic-like effects of m4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release. Neuron. 2016;91:1244\u201352.","journal-title":"Neuron."},{"key":"885_CR74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejphar.2015.08.001","volume":"764","author":"H-I Cho","year":"2015","unstructured":"Cho H-I, Hong J-M, Choi J-W, Choi H-S, Kwak JH, Lee D-U, et al. \u03b2-caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. Eur J Pharmacol. 2015;764:613\u201321.","journal-title":"Eur J Pharmacol."},{"key":"885_CR75","doi-asserted-by":"publisher","first-page":"116915","DOI":"10.1016\/j.lfs.2019.116915","volume":"237","author":"N Irrera","year":"2019","unstructured":"Irrera N, D\u2019Ascola A, Pallio G, Bitto A, Mazzon E, Mannino F, et al. \u03b2-caryophyllene mitigates collagen antibody induced arthritis (CAIA) in mice through a cross-talk between CB2 and PPAR-\u03b3 receptors. Life Sci. 2019;237:116915. https:\/\/doi.org\/10.1016\/j.lfs.2019.116915.","journal-title":"Life Sci"},{"key":"885_CR76","doi-asserted-by":"crossref","first-page":"116915","DOI":"10.1016\/j.lfs.2019.116915","volume":"237","author":"X Tian","year":"2019","unstructured":"Tian X, Liu H, Xiang F, Xu L, Dong Z. \u03b2-Caryophyllene protects against ischemic stroke by promoting polarization of microglia toward M2 phenotype via the TLR4 pathway. Life Sci. 2019;237:116915.","journal-title":"Life Sci"},{"key":"885_CR77","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.bmcl.2014.04.112","volume":"24","author":"C Wu","year":"2014","unstructured":"Wu C, Jia Y, Lee JH, Jun H, Lee H-S, Hwang K-Y, et al. Trans-caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-\u03b1. Bioorg Med Chem Lett. 2014;24:3168\u201374.","journal-title":"Bioorg Med Chem Lett."},{"key":"885_CR78","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2017.01.007","volume":"116","author":"CN Haile","year":"2017","unstructured":"Haile CN, Kosten TA. The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats. Neuropharmacology. 2017;116:364\u201370.","journal-title":"Neuropharmacology."},{"key":"885_CR79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.03.005","volume":"118","author":"A Jackson","year":"2017","unstructured":"Jackson A, Bagdas D, Muldoon PP, Lichtman AH, Carroll FI, Greenwald M, et al. In vivo interactions between \u03b17 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-\u03b1: Implication for nicotine dependence. Neuropharmacology. 2017;118:38\u201345.","journal-title":"Neuropharmacology."},{"key":"885_CR80","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2174\/1389450111314070006","volume":"14","author":"B Le Foll","year":"2013","unstructured":"Le Foll B, Di Ciano P, Panlilio LV, Goldberg SR, Ciccocioppo R. Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence. Curr Drug Targets. 2013;14:768\u201376.","journal-title":"Curr Drug Targets."},{"key":"885_CR81","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2010.07.009","volume":"69","author":"P Mascia","year":"2011","unstructured":"Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, et al. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biol Psychiatry. 2011;69:633\u201341.","journal-title":"Biol Psychiatry."},{"key":"885_CR82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-016-4452-1","volume":"234","author":"G de Guglielmo","year":"2017","unstructured":"de Guglielmo G, Kallupi M, Scuppa G, Demopulos G, Gaitanaris G, Ciccocioppo R. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents. Psychopharmacol. 2017;234:223\u201334.","journal-title":"Psychopharmacol."},{"key":"885_CR83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/adb.12471","volume":"23","author":"WR Miller","year":"2018","unstructured":"Miller WR, Fox RG, Stutz SJ, Lane SD, Denner L, Cunningham KA, et al. PPAR\u03b3 agonism attenuates cocaine cue reactivity. Addict Biol. 2018;23:55\u201368.","journal-title":"Addict Biol"},{"key":"885_CR84","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/add.13868","volume":"112","author":"JM Schmitz","year":"2017","unstructured":"Schmitz JM, Green CE, Hasan KM, Vincent J, Suchting R, Weaver MF, et al. PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial. Addiction. 2017;112:1861\u20138.","journal-title":"Addiction."},{"key":"885_CR85","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1523\/JNEUROSCI.1922-19.2019","volume":"39","author":"E Domi","year":"2019","unstructured":"Domi E, Caputi FF, Romualdi P, Domi A, Scuppa G, Candeletti S, et al. Activation of PPAR\u03b3 attenuates the expression of physical and affective nicotine withdrawal symptoms through mechanisms involving amygdala and hippocampus neurotransmission. J Neurosci. 2019;39:9864\u201375.","journal-title":"J Neurosci"},{"key":"885_CR86","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.npp.1301213","volume":"32","author":"T Maeda","year":"2007","unstructured":"Maeda T, Kiguchi N, Fukazawa Y, Yamamoto A, Ozaki M, Kishioka S. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice. Neuropsychopharmacology. 2007;32:1133\u201340.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR87","doi-asserted-by":"crossref","first-page":"e0201512","DOI":"10.1371\/journal.pone.0201512","volume":"13","author":"MNS Gendy","year":"2018","unstructured":"Gendy MNS, Di Ciano P, Kowalczyk WJ, Barrett SP, George TP, Heishman S, et al. Testing the PPAR hypothesis of tobacco use disorder in humans: a randomized trial of the impact of gemfibrozil (a partial PPAR\u03b1 agonist) in smokers. PLoS ONE. 2018;13:e0201512.","journal-title":"PLoS ONE"},{"key":"885_CR88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","volume":"425","author":"J Fu","year":"2003","unstructured":"Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodr\u00edguez De Fonseca F, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003;425:90\u20133.","journal-title":"Nature."},{"key":"885_CR89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1871527311312010012","volume":"12","author":"M Melis","year":"2013","unstructured":"Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type \u03b1 on dopamine systems. CNS Neurol Disord Drug Targets. 2013;12:70\u20137.","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"885_CR90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2005.05.032","volume":"517","author":"M Bouaboula","year":"2005","unstructured":"Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur J Pharmacol. 2005;517:174\u201381.","journal-title":"Eur J Pharmacol."},{"key":"885_CR91","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","volume":"123","author":"S Moreno","year":"2004","unstructured":"Moreno S, Farioli-Vecchioli S, Cer\u00f9 MP. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience. 2004;123:131\u201345.","journal-title":"Neuroscience."},{"key":"885_CR92","doi-asserted-by":"crossref","DOI":"10.1038\/srep27618","volume":"6","author":"A Warden","year":"2016","unstructured":"Warden A, Truitt J, Merriman M, Ponomareva O, Jameson K, Ferguson LB, et al. Localization of PPAR isotypes in the adult mouse and human brain. Sci Rep. 2016;6:27618.","journal-title":"Sci Rep."},{"key":"885_CR93","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/en.2008-0899","volume":"150","author":"DA Sarruf","year":"2009","unstructured":"Sarruf DA, Yu F, Nguyen HT, Williams DL, Printz RL, Niswender KD, et al. Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis. Endocrinology. 2009;150:707\u201312.","journal-title":"Endocrinology."},{"key":"885_CR94","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2010.04.016","volume":"68","author":"M Melis","year":"2010","unstructured":"Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, et al. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biol Psychiatry. 2010;68:256\u201364.","journal-title":"Biol Psychiatry."},{"key":"885_CR95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1369-1600.2010.00222.x","volume":"15","author":"A Luchicchi","year":"2010","unstructured":"Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, et al. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addict Biol. 2010;15:277\u201388.","journal-title":"Addict Biol."},{"key":"885_CR96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2017.126","volume":"43","author":"JM Wenzel","year":"2018","unstructured":"Wenzel JM, Cheer JF. Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling. Neuropsychopharmacology. 2018;43:103\u201315.","journal-title":"Neuropsychopharmacology."},{"key":"885_CR97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pbb.2005.01.032","volume":"81","author":"EL Gardner","year":"2005","unstructured":"Gardner EL. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharm Biochem Behav. 2005;81:263\u201384.","journal-title":"Pharm Biochem Behav."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00885-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T01:12:32Z","timestamp":1634433152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00885-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["885"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-00885-4","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,17]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}